Trial intelligence / Profile preview

Genicular Nerve Block for Analgesia After Open Reduction Internal Fixation of Tibial Plateau Fractures

NCT06639503Phase 1Recruiting

Sponsor
University of Chicago
Start
Nov 2024
Primary completion
Sep 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by University of Chicago. Primary endpoint: Visual Analog Scale Pain Rating. Started Nov 2024; status: recruiting.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06639503.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06639503.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call